ChemChina’s proposed $43bn acquisition of Syngenta will not be derailed by Australian competition regulators, who have green-lighted the deal saying it had no competition concerns.
Australia’s Competition and Consumer Commission (ACCC) had been scrutinizing the deal, the biggest ever foreign takeover by a Chinese company, as ChemChina owns a subsidiary, Adama Agricultural Solutions (Adama), which competes with Syngenta in Australia as they both supply crop protection products such as insecticides, herbicides, and fungicides.
However, regulators found there was no concerns, as ChemChina would still face competition from Bayer, BASF, Monsanto, Dow and others.
“The ACCC found that ChemChina would continue to face competition in the supply of crop protection products from a range of proprietary and generic suppliers such as Bayer, BASF, Monsanto, Nufarm, Dow, DuPont, and FMC,” ACCC chairman Rod Sims said.
“Importantly, the ACCC also took into account the complementary nature of the two businesses. Syngenta is focused on research and development to bring new patented chemicals to market. Adama focuses on generic off-patent chemicals.”
“Generic chemicals are more prevalent in Australia than in many other countries, and there is a large number of suppliers. Bringing new generic chemicals to market is often cheaper and quicker in Australia than, for example, in the European Union, due to lower regulatory barriers,” Sims added.
Full Content: Food Ingredients First
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
UK Probes Lindab’s Acquisition of HAS-Vent Amid Fears of Market Monopoly
Apr 28, 2024 by
CPI
Shein Faces EU Regulations Over User Data
Apr 28, 2024 by
CPI
Google Fights Back Against US Antitrust Lawsuit
Apr 28, 2024 by
CPI
US Homeland Security Establishes Blue-Ribbon Board with Tech CEOs to Advise on AI
Apr 28, 2024 by
CPI
FTC Accuses Amazon Executives of Using Disappearing Messaging Apps to Conceal Evidence
Apr 28, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI